Danske Bank’s Bristol-Myers Squibb BMY Stock Holding History

Danske Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$87.7M	Buy	1,445,624 +223,921	+18%	+$13.1M	0.21%	90
2025 Q4	$65.9M	Sell	1,221,703 -365,674	-23%	-$17.6M	0.15%	120
2025 Q3	$71.6M	Buy	1,587,377 +262,685	+20%	+$12.3M	0.18%	103
2025 Q2	$61.3M	Sell	1,324,692 -327,066	-20%	-$16.1M	0.15%	122
2025 Q1	$101M	Buy	1,651,758 +111,006	+7%	+$6.47M	0.31%	53
2024 Q4	$87.1M	Buy	1,540,752 +494,973	+47%	+$27.7M	0.26%	64
2024 Q3	$54.1M	Buy	1,045,779 +140,990	+16%	+$6.61M	0.18%	102
2024 Q2	$37.6M	Sell	904,789 -162,975	-15%	-$7.29M	0.14%	131
2024 Q1	$57.9M	Buy	+1,067,764	New	+$54.4M	0.18%	106

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Danske Bank's BMY Position: Q1 2026 in Review

Danske Bank increased its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, buying an estimated $13.1M and bringing the position to 1,445,624 shares worth $87.7M. The position accounts for 0.21% of the portfolio, ranked #90.

Danske Bank first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. The position peaked at $101M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Danske Bank held 1,445,624 shares of Bristol-Myers Squibb worth $87.7M as of Q1 2026.
Danske Bank bought 223,921 Bristol-Myers Squibb shares in Q1 2026, an estimated $13.1M.
Bristol-Myers Squibb made up 0.21% of Danske Bank's portfolio in Q1 2026, its #90 holding.
Danske Bank first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
Danske Bank's Bristol-Myers Squibb position peaked at $101M in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.